Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
Abstract Introduction Lurasidone is an atypical antipsychotic that was approved in Europe in 2014 for the treatment of schizophrenia in adults aged ≥ 18 years. Clinical experience with lurasidone in Europe is currently limited, and there is therefore a need to provide practical guidance on using lur...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2019-05-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1007/s40120-019-0138-z |